Follow
Nicholas G. Nickols
Nicholas G. Nickols
UCLA David Geffen School of Medicine
Verified email at mednet.ucla.edu
Title
Cited by
Cited by
Year
Size-selective collection of circulating tumor cells using Vortex technology
E Sollier, DE Go, J Che, DR Gossett, S O'Byrne, WM Weaver, N Kummer, ...
Lab on a Chip 14 (1), 63-77, 2014
5712014
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 …
AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ...
Jama 319 (9), 896-905, 2018
2992018
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
BZ Olenyuk, GJ Zhang, JM Klco, NG Nickols, WG Kaelin Jr, PB Dervan
Proceedings of the National Academy of Sciences 101 (48), 16768-16773, 2004
2862004
68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage …
J Calais, J Czernin, M Cao, AU Kishan, JV Hegde, N Shaverdian, ...
Journal of Nuclear Medicine 59 (2), 230-237, 2018
2652018
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ...
JAMA network open 2 (2), e188006-e188006, 2019
2562019
Nuclear localization of pyrrole–imidazole polyamide–fluorescein conjugates in cell culture
TP Best, BS Edelson, NG Nickols, PB Dervan
Proceedings of the National Academy of Sciences 100 (21), 12063-12068, 2003
2472003
Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide
NG Nickols, PB Dervan
Proceedings of the National Academy of Sciences 104 (25), 10418-10423, 2007
2342007
Modulating hypoxia-inducible transcription by disrupting the HIF-1–DNA interface
NG Nickols, CS Jacobs, ME Farkas, PB Dervan
ACS chemical biology 2 (8), 561-571, 2007
1662007
A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)
LF Valle, EJ Lehrer, D Markovic, D Elashoff, R Levin-Epstein, RJ Karnes, ...
European urology 80 (3), 280-292, 2021
1652021
Influence of structural variation on nuclear localization of DNA‐binding polyamide‐fluorophore conjugates
BS Edelson, TP Best, B Olenyuk, NG Nickols, RM Doss, S Foister, ...
Nucleic acids research 32 (9), 2802-2818, 2004
1602004
Impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence
J Calais, WP Fendler, M Eiber, J Gartmann, FI Chu, NG Nickols, RE Reiter, ...
Journal of Nuclear Medicine 59 (3), 434-441, 2018
1522018
Improved nuclear localization of DNA-binding polyamides
NG Nickols, CS Jacobs, ME Farkas, PB Dervan
Nucleic acids research 35 (2), 363-370, 2007
1482007
Antitumor activity of a pyrrole-imidazole polyamide
F Yang, NG Nickols, BC Li, GK Marinov, JW Said, PB Dervan
Proceedings of the National Academy of Sciences 110 (5), 1863-1868, 2013
1402013
Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression
KA Muzikar, NG Nickols, PB Dervan
Proceedings of the National Academy of Sciences 106 (39), 16598-16603, 2009
1292009
Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
J Calais, J Czernin, WP Fendler, D Elashoff, NG Nickols
BMC cancer 19, 1-11, 2019
1122019
Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings: a prospective single-center study
I Sonni, M Eiber, WP Fendler, RM Alano, SS Vangala, AU Kishan, ...
Journal of Nuclear Medicine 61 (8), 1153-1160, 2020
1102020
Clinical outcomes for patients with Gleason score 9–10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis
AU Kishan, T Shaikh, PC Wang, RE Reiter, J Said, G Raghavan, ...
European urology 71 (5), 766-773, 2017
1042017
Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial
AU Kishan, TM Ma, JM Lamb, M Casado, H Wilhalme, DA Low, K Sheng, ...
JAMA oncology 9 (3), 365-373, 2023
962023
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
NG Nickols, R Nazarian, SG Zhao, V Tan, V Uzunangelov, Z Xia, ...
Prostate cancer and prostatic diseases 22 (4), 531-538, 2019
902019
Potential impact of 68Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer
J Calais, AU Kishan, M Cao, WP Fendler, M Eiber, K Herrmann, F Ceci, ...
Journal of Nuclear Medicine 59 (11), 1714-1721, 2018
742018
The system can't perform the operation now. Try again later.
Articles 1–20